Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:19:41

Checking in with Alector CEO Arnon Rosenthal ahead of...

BiotechTV - News ·

2025/08/13

Dr. Rosenthal describes the unmet need in frontotemporal dementia and mechanism of action of latozinemab. He covers the trial design and explains why a new co-primary endpoint was recently added to the statistical plan. Plus, developing a similar medicine for early stage Alzheimer's, and how Alector is trying to get therapies across the blood-brain barrier more efficiently.

en-us

00:18:01

IDEAYA Biosciences is at the forefront of precision...

BiotechTV - News ·

2025/08/12

Founder & CEO Yujiro Hata describes the idea behind precision medicine and synthetic lethality. We discuss the company's pipeline assets Darovasertib, a DLL3 ADC, MAT2A, and more.

en-us

00:18:47

CytomX Therapeutics' years of work on its 'Probody'...

BiotechTV - News ·

2025/08/12

Chairman & CEO Sean McCarthy walks us through the science and describes what CytomX has learned about it over many years of working on masking. He discusses the recent EpCAM data, and highlights IFN-α2b and partnered programs.

en-us

00:14:21

Maze Therapeutics, which had its IPO earlier this...

BiotechTV - News ·

2025/08/12

CEO Jason Coloma walks us through the science that is taking place at the company's South San Francisco headquarters, and descrbies the development programs. The lead program for APOL1-Mediated Kidney Disease is in phase 2, and a second for PKU and Chronic Kidney Disease will have important healthy volunteer proof of concept data this quarter.

en-us

00:12:51

Astria Therapeutics licensed its HAE treatment,...

BiotechTV - News ·

2025/08/07

President and CEO Jill Milne describes what she believes is the unmet need and profile of Navenibart, and walks us through future anticipated developments. Plus, discussing the company's OX40 antagonist for atopic dermatitis that will have key healthy volunteer proof of concept data in the third quarter of this year.

en-us

00:18:33

AI News: While most AI in healthcare is aimed at...

BiotechTV - News ·

2025/08/07

Founder & CEO Steve Brown, who created CureWise after receiving his own diagnosis of a rare blood cancer, describes his journey and how CureWise is meant to help patients. Its goal is to start with a diversity of opinions from multiple sources and help them converge on a diagnosis.

en-us

00:19:27

From Indianapolis: Serial entrepreneur Derek Small...

BiotechTV - News ·

2025/08/05

He discusses the idea behind Syndeio, which focuses on synaptic function and has a lead program in major depressive disorder. Plus, other work he is doing, and Derek's take on the growth and maturity of the biotech ecosystem in Indiana.

en-us

00:06:11

From Indianapolis: Adipo Therapeutics is approaching...

BiotechTV - News ·

2025/08/05

CEO Karen Wurster describes the science behind the company, which recently presented proof-of-concept data from human cells at the ADA meeting. Plus, what it is like working from the IBRI in Indianapolis and being an Indiana biotech company.

en-us

00:09:11

The Indiana Biosciences Research Institute is a...

BiotechTV - News ·

2025/08/05

IBRI CEO Alan Palkowitz descrbies the work that takes place at the IBRI, which includes both the institute's own research and how it acts as an incubator to biotech companies. Plus, the state of biotech in Indiana and what its strengths are here.

en-us

00:10:38

BiotechTV visits Indiana University School of...

BiotechTV - News ·

2025/08/04

Dr. Lamb, a noted expert in neuroscience and Alzheimer's research, introduces us to Stark and describes the investment in people and equipment that has been made here. The institute has two key focuses of 1) modeling Alzheimer's disease and 2) how to expedite research understandings to treat it. Plus, he discusses a company he has co-founded, called Monument Biosciences, that is focusing on the neuroinflamatory side of the disease.

en-us

00:25:48

Former NIH Director and Co-Founder of ModeX...

BiotechTV - News ·

2025/07/30

He highlights his new memoir, Disease Knows No Politics, and gives his opinion on what is at stake in preserving NIH and other scientific funding. Plus, how ModeX is working on multispecifics for cancer and autoimmune conditions, and multivalent vaccines.

en-us

00:09:41

AI x Bio Summit: Proscia CEO David West describes how...

BiotechTV - News ·

2025/07/25

He describes how computing power in pathology is augmenting the work that pathologists traditionally do, but also is becoming an increasing important tool in precision medicine.

en-us

00:18:31

Monte Rosa Therapeutics' CEO Markus Warmuth updates...

BiotechTV - News ·

2025/07/24

The company, which recently had a paper earn a spot on the cover of Science, is progressing ahead with both I&I and oncology indications. Dr. Warmuth walks us through the pipeline progress and overall strategy of finding and pursuing targets.

en-us

00:26:55

Abivax CEO Marc de Garidel discusses Obefazimod's...

BiotechTV - News ·

2025/07/24

He covers the mechanism of action, this week's efficacy and safety data, what it might mean for the maintenance trial that will read out in 2Q26, additional indications, IP, business development, and more.

en-us

00:15:24

AI x Bio Summit: Recursion's Chief R&D Officer & CCO...

BiotechTV - News ·

2025/07/24

She describes Recursion's work, and what the acquisition of Exscientia has brought to the company. Plus, how AI can not only help with drug design, but also safety and patient recruitment.

en-us

00:20:25

After receiving a CRL for its RP1 oncolytic...

BiotechTV - News ·

2025/07/23

CEO Sushil Patel walks us through the decisions behind the design of the IGNYTE phase 1/2 study and the ongoing IGNYTE-3 study, he gives Replimune's impression of how the review went since the BLA was filed last November, and he discusses what the CRL could mean for the future.

en-us

00:10:41

AI x Bio Summit: The CEO of Alto Neuroscience, which...

BiotechTV - News ·

2025/07/23

Amit Etkin says Alto Neuro is trying to use machine learning to understand signals from the complexity of the brain, and the company is also embedding AI in its clinical trials in order to collect as much information from the field as possible. He also walks us through the company's program.

en-us

00:10:06

NYSE Strategist Eric Criscuolo shares his take on the...

BiotechTV - News ·

2025/07/23

He discusses the importance of interest rates to high risk sectors like biotech, and comment on how our sector has not performed lately like other "risk-on" assets have. Plus, explaining his job of helping CEOs of NYSE listed companies understand the economic and capital markets environment.Note: The NYSE is a sponsor of BiotechTV

en-us

00:12:47

AI x Bio Summit: The Co-Founder and Head of Machine...

BiotechTV - News ·

2025/07/22

Sam Sinai talks about how capsids are being more precisely designed today, which is allowing drug developers to better target them to different organs and to improve their efficiency. Plus, why he believes AI will help make cell and gene therapies reach more patients in the future.

en-us

00:10:08

RBC's Healthcare Desk Strategist Chris McCarthy...

BiotechTV - News ·

2025/07/22

He highlights recent M&A, but also notes how the sector has not been reliant on deals like it has in the past. Plus, discussing how Sarepta's wild ride has not led to contagion, and previewing what key data events are upcoming.

en-us

486 results

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

Sleep Science

Sleep Science

PBS News Hour - Science

PBS News

Sur les traces de la Préhistoire

ICI Périgord

La Brújula de la Ciencia

Alberto Aparici